Adaptive DBS – a new approach to improve PD symptoms

Deep brain stimulation (DBS) is a surgical procedure in which thin electrodes are implanted into parts of the brain...see more to alter brain circuitry. It is used in the treatment of several neurologic conditions including Parkinson’s disease (PD), in which the electricity disrupts abnormal brain signals that allows the brain to restore more normal movement. Currently, […]

Read More

Recently published research on induced pluripotent stem cells by APDA-funded researchers

APDA-funded researchers at Brigham and Women’s Hospital, including Drs. Isabel Lam and Anastasia Kuzkina, under the leadership of Dr. ...see more Vikram Khurana, the Director of APDA’s Center for Advanced Research at Brigham and Women’s Hospital, recently published a paper demonstrating a novel technology that more rapidly turns stem cells created from the cells of an adult […]

Read More

Crexont®: A Newly Approved Parkinson’s Medication

New Carbidopa/Levodopa Formulation Approved for Reducing OFF Time Amneal Pharmaceuticals, Inc. announced today that their new medication IPX203, now known as...see more Crexont®, was approved by the Food and Drug Administration. Crexont is a novel oral formulation of carbidopa-levodopa extended-release capsules. Similar to Amneal’s Rytary, it contains both immediate-release and extended-release elements in the capsule and is designed […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW

APDA remains steadfast in its mission to support those impacted by Parkinson’s disease as new law provides hope for...see more accelerated progress toward a cure NEW YORK, NY, JULY 3, 2024 – The American Parkinson Disease Association (APDA) is celebrating the President’s signing of the National Plan to End Parkinson’s Act yesterday, marking the enactment of […]

Read More

Historic News for the PD Community

The National Plan to End Parkinson’s Act Has Been Signed into Law Today we celebratethe President’s signing of the...see more National Plan to End Parkinson’s Act, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson’s disease (PD) and ensuring quality care for those impacted by this chronic and progressive neurologic disease. […]

Read More